ZEMDAP® – L Tablet

ZEMDAP® – L is a fixed-dose combination of Linagliptin, a DPP-4 inhibitor, and Dapagliflozin, an SGLT2 inhibitor, formulated to provide broad and complementary glycemic control in adults with type 2 diabetes mellitus. This once-daily oral therapy improves both fasting and postprandial glucose levels, while also supporting weight loss, blood pressure reduction, and offering cardiorenal protection — without increasing the risk of hypoglycemia.

Categories: ,

Description

Composition (Each Film-Coated Tablet Contains):

  • Linagliptin – 5 mg

  • Dapagliflozin – 10 mg

Category: Diabetes Care / SGLT2 + DPP-4 Inhibitor Combination
Form: Oral Tablet
Pack Size: 10×10 Alu-Alu or Blister Pack


Product Description:

ZEMDAP® – L is a fixed-dose combination of Linagliptin, a DPP-4 inhibitor, and Dapagliflozin, an SGLT2 inhibitor, formulated to provide broad and complementary glycemic control in adults with type 2 diabetes mellitus. This once-daily oral therapy improves both fasting and postprandial glucose levels, while also supporting weight loss, blood pressure reduction, and offering cardiorenal protection — without increasing the risk of hypoglycemia.


Key Benefits:

  • Targets both renal and incretin pathways to control blood sugar

  • Helps reduce HbA1c, fasting, and post-meal glucose

  • Low risk of hypoglycemia when used without insulin

  • Effective in overweight and hypertensive diabetic patients

  • Once-daily dosing with proven cardiovascular and renal benefits


How it works:

  • Dapagliflozin promotes urinary glucose excretion by inhibiting SGLT2 in the renal tubules, reducing plasma glucose levels and body weight.

  • Linagliptin inhibits the DPP-4 enzyme, thereby increasing active incretin hormones (GLP-1 and GIP) that enhance insulin secretion and suppress glucagon release in a glucose-dependent manner.

Together, they offer synergistic blood sugar regulation with additional metabolic advantages.


How to use:

  • Take one tablet once daily, preferably in the morning, with or without food, or as advised by your doctor.

  • Swallow whole with water. Do not split or crush the tablet.

  • Ensure consistent use and maintain proper hydration.

  • Regularly monitor blood glucose and kidney function.


Safety Advice:

  • Well tolerated with a low risk of hypoglycemia

  • May cause mild urinary or genital infections — stay hydrated and maintain hygiene

  • Monitor renal function periodically, especially in elderly patients

  • Inform your doctor if you develop symptoms of dehydration or dizziness


Precautions:

  • Not for use in type 1 diabetes or diabetic ketoacidosis (DKA)

  • Caution in patients with chronic kidney disease, recurrent UTIs, or pancreatitis

  • Not recommended during pregnancy or breastfeeding

  • Disclose all other antidiabetic or diuretic medications to your doctor


Storage:

Store in a cool, dry place below 25°C. Protect from moisture and direct light.
Keep out of reach of children.

Reviews

There are no reviews yet.

Be the first to review “ZEMDAP® – L Tablet”

Your email address will not be published. Required fields are marked *